162 related articles for article (PubMed ID: 17175953)
21. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
22. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
Zhao Z; Wang G; Na YQ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
[TBL] [Abstract][Full Text] [Related]
23. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
24. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
25. Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptoms.
Dineen MK; Shore ND; Lumerman JH; Saslawsky MJ; Corica AP
Urology; 2008 May; 71(5):873-7. PubMed ID: 18374395
[TBL] [Abstract][Full Text] [Related]
26. Seasonal changes in symptom score and uroflowmetry in patients with lower urinary tract symptoms.
Watanabe T; Maruyama S; Maruyama Y; Kageyama S; Shinbo H; Otsuka A; Ozono S
Scand J Urol Nephrol; 2007; 41(6):521-6. PubMed ID: 17853015
[TBL] [Abstract][Full Text] [Related]
27. A community based study of prostatic symptoms in Singapore.
Tan HY; Choo WC; Archibald C; Esuvaranathan K
J Urol; 1997 Mar; 157(3):890-3. PubMed ID: 9072593
[TBL] [Abstract][Full Text] [Related]
28. [Lower urinary tract symptoms are poorly correlated with erectile dysfunction].
Marionneau N; Perrin P; Taieb C
Prog Urol; 2006 Nov; 16(5):572-7. PubMed ID: 17175954
[TBL] [Abstract][Full Text] [Related]
29. [Validation of a French adaptation of the international prostatic symptom score].
Grégoire JP; Moisan J; Labrecque M; Cusan L; Diamond P
Prog Urol; 1996 Apr; 6(2):240-9. PubMed ID: 8777417
[TBL] [Abstract][Full Text] [Related]
30. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
31. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
[TBL] [Abstract][Full Text] [Related]
33. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
35. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
36. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
37. [Adaptation and validation in the French language of the International Score of Symptoms of Benign Prostatic Hypertrophy].
Sagnier PP; Richard F; Botto H; Teillac P; Dreyfus JP; Boyle P
Prog Urol; 1994; 4(4):532-8; discussion 539-40. PubMed ID: 7522745
[TBL] [Abstract][Full Text] [Related]
38. [A modified IPSS score: value of a choice of qualitative answers].
Perrin P; Némoz C; Paparel P; Ruffion A
Prog Urol; 2006 Apr; 16(2):168-73. PubMed ID: 16734240
[TBL] [Abstract][Full Text] [Related]
39. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
40. Is questionnaire enough to assess number of nocturic episodes? Prospective comparative study between data from questionnaire and frequency-volume charts.
Ku JH; Hong SK; Kim HH; Paick JS; Lee SE; Oh SJ
Urology; 2004 Nov; 64(5):966-9. PubMed ID: 15533487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
